Rheumatology

Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…

Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…

Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…

Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…

Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…

The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…

Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…